Theravance Biopharma Inc (TBPH) — Free Cash Flow Generation Index
Theravance Biopharma Inc (TBPH) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $208.04 Million represents 1% of operating cash flow ($208.07 Million). Explore Theravance Biopharma Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Theravance Biopharma Inc Free Cash Flow Generation Index (2025–2025)
Historical FCF Generation Index trend for Theravance Biopharma Inc across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Theravance Biopharma Inc.
Annual Free Cash Flow Generation for Theravance Biopharma Inc (2025–2025)
Year-by-year Free Cash Flow Generation Index for Theravance Biopharma Inc. Check Theravance Biopharma Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $238.50 Million | $238.54 Million | $42.00K | — |